Feng Wang
@fengwan25720657
Professor and Director of Medical Oncology dept from Sun Yat-sen University Cancer Center. UT MD Anderson alumni
ID: 1111592948574101504
29-03-2019 11:36:26
121 Tweet
225 Followers
268 Following
The Capability-01 trial was just published. The combination of HADCi, anti-PD-1 and anti-VEGF achieved an ORR of 44% with a mPFS 7.3 mos in MSS mCRC patients. Thanks to the study team, all patients and family. #colorectalcancer #Immunology #Cancer Nature Medicine
